MiMedx Group Inc (MDXG)
9.20
-0.02
(-0.22%)
USD |
NASDAQ |
Nov 22, 16:00
9.19
-0.01
(-0.11%)
After-Hours: 20:00
MiMedx Group Price to Free Cash Flow
Price to Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Free Cash Flow Data
| Date | Value |
|---|---|
| November 22, 2024 | -- |
| November 21, 2024 | -- |
| November 20, 2024 | -- |
| November 19, 2024 | -- |
| November 18, 2024 | -- |
| November 15, 2024 | -- |
| November 14, 2024 | -- |
| November 13, 2024 | -- |
| November 12, 2024 | -- |
| November 11, 2024 | -- |
| November 08, 2024 | -- |
| November 07, 2024 | -- |
| November 06, 2024 | -- |
| November 05, 2024 | -- |
| November 04, 2024 | -- |
| November 01, 2024 | -- |
| October 31, 2024 | -- |
| October 30, 2024 | -- |
| October 29, 2024 | -- |
| October 28, 2024 | -- |
| October 25, 2024 | -- |
| October 24, 2024 | -- |
| October 23, 2024 | -- |
| October 22, 2024 | -- |
| October 21, 2024 | -- |
| Date | Value |
|---|---|
| October 18, 2024 | -- |
| October 17, 2024 | -- |
| October 16, 2024 | -- |
| October 15, 2024 | -- |
| October 14, 2024 | -- |
| October 11, 2024 | -- |
| October 10, 2024 | -- |
| October 09, 2024 | -- |
| October 08, 2024 | -- |
| October 07, 2024 | -- |
| October 04, 2024 | -- |
| October 03, 2024 | -- |
| October 02, 2024 | -- |
| October 01, 2024 | -- |
| September 30, 2024 | -- |
| September 27, 2024 | -- |
| September 26, 2024 | -- |
| September 25, 2024 | -- |
| September 24, 2024 | -- |
| September 23, 2024 | -- |
| September 20, 2024 | -- |
| September 19, 2024 | -- |
| September 18, 2024 | -- |
| September 17, 2024 | -- |
| September 16, 2024 | -- |
Price to Cash Flow Definition
Price to free cash flow measures the Price / TTM Free Cash Flow. Like other price ratios (ie. PE Ratio, PS Ratio, P/B Ratio), this metric can be used to compare companies with similar capital structures. Free cash flow gives an idea of how much cash is available for shareholders through stock buybacks and dividend payouts. A lower price to free cash flow is more desirable when assessing different companies.